Home
>
US Stocks
>
Ambrx Biopharma Inc - ADR
Ambrx Biopharma Inc - ADR
AMAM

Ambrx Biopharma Inc - ADR

$12.4211.89%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
11.36
Today Low/High
11.36 / 12.42
52 Week Low/High
$11.04 / $22.87
Market Cap
$418.13M

Company Details

Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. These include next generation antibody drug conjugates (ADCs), bispecifics, targeted immuno-oncology therapies, novel cytokines to modulate the immune system, and long-acting therapeutic peptides for metabolic and cardiovascular disease. Ambrx is advancing a robust portfolio of clinical and preclinical programs designed to optimize efficacy, safety and ease of use, in multiple therapeutic areas, including its lead product candidate ARX788. In addition, the company has clinical collaborations with Bristol Myers Squibb, Astellas, BeiGene, Sino Biopharma, Elanco and NovoCodex, for drug candidates generated using Ambrx technology.
Organisation
Ambrx Biopharma Inc - ADR

Discover more

Frequently Asked Questions

What is Ambrx Biopharma Inc - ADR share price today

Can Indians buy Ambrx Biopharma Inc - ADR shares?

How can I buy Ambrx Biopharma Inc - ADR shares from India?

Can Fractional shares of Ambrx Biopharma Inc - ADR be purchased?

What are the documents required to start investing in Ambrx Biopharma Inc - ADR stocks?

We are a SEBI registered investement advisor